Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

FRA/BZ7A stock hub

FRA/BZ7A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/BZ7Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/BZ7A

In the news

Latest news · FRA/BZ7A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.3

P25 12.3P50 15.7P75 20.2

Trailing P/E18.6

P25 16.4P50 20.9P75 30.4

ROE24.4

P25 -6.7P50 8.5P75 17.2

ROIC41.3

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/BZ7A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

THB

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Thailand
Country code	DE
Employees	3,253
Enterprise value	EUR 3.4B
Exchange	Frankfurt Stock Exchange
Financial currency	THB
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	TH0168A10Z19
Last refreshed	2026-05-10
Market cap	EUR 3.7B
Price	EUR 4.66
Price currency	EUR
Rev Per Employee	208,238.64x
Sector	Healthcare
Sic	8062
Symbol	fra/BZ7A
Website	https://www.bumrungrad.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.37%
EV Earnings	16.78x
EV/EBIT	13.94x
EV/EBITDA	12.59x
EV/FCF	25.35x
EV/Sales	5.02x
FCF yield	3.56%
Forward P/E	18.28x
P/B ratio	4.27x
P/E ratio	18.61x
P/S ratio	5.52x
PE Ratio10 Y	44.19x
PE Ratio3 Y	22.3x
PE Ratio5 Y	43.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	36.01%
EBITDA Margin	39.78%
FCF margin	19.66%
Gross margin	52.4%
Gross Profit	EUR 355M
Gross Profit Growth	1.91%
Gross Profit Growth Q	1.88%
Gross Profit Growth3 Y	6.72%
Gross Profit Growth5 Y	28.16%
Net Income	EUR 201.1M
Net Income Growth	0.59%
Net Income Growth Q	3.24%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	9.3%
Net Income Growth5 Y	70.19%
Pretax Margin	36.84%
Profit Margin	29.69%
Profit Per Employee	EUR 61,826
Profitable Years	23
ROA	15.71
Roa5y	15.17
ROCE	26.82
ROE	24.38
Roe5y	24.22
ROIC	41.31
Roic5y	40.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.72%
Cagr15y	15.04%
Cagr1y	14.5%
Cagr20y	16.37%
Cagr3y	-6.69%
Cagr5y	8.69%
Div CAGR10	16.9%
Div CAGR3	43.82%
Div CAGR5	27.95%
EPS Growth	0.58
EPS Growth Q	3
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	9.29
EPS Growth5 Y	69.68
FCF Growth	-29.76%
FCF Growth Q	-75.45%
FCF Growth3 Y	-4.96%
FCF Growth5 Y	26.69%
OCF Growth	-8.18%
OCF Growth Q	-26.22%
OCF Growth10 Y	5.99%
OCF Growth3 Y	2.94%
OCF Growth5 Y	25.82%
Revenue Growth	-0.06x
Revenue Growth Q	0.67x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	3.72x
Revenue Growth5 Y	18.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.7
Assets	EUR 1B
Cash	EUR 381.1M
Current Assets	EUR 529.3M
Current Liabilities	EUR 118M
Debt	EUR 2.8M
Debt EBITDA	EUR 0.01
Debt Equity	EUR 0
Debt FCF	EUR 0.02
Equity	EUR 876.3M
Interest Coverage	1,525.2
Liabilities	EUR 152.4M
Long Term Assets	EUR 499.5M
Long Term Liabilities	EUR 34.4M
Net Cash	EUR 378.3M
Net Cash By Market Cap	EUR 10.11
Net Cash Growth	2.81%
Net Debt EBITDA	EUR -1.4
Net Debt Equity	EUR -0.43
Net Debt FCF	EUR -2.84
Tangible Book Value	EUR 847.7M
Tangible Book Value Per Share	EUR 1.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.48
Inventory Turnover	39.18
Net Working Capital	EUR 34.7M
Quick ratio	4.37
Working Capital	EUR 415.2M
Working Capital Turnover	EUR 0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	120.01%
Dividend Growth Years	4%
Dividend per share	EUR 0.29
Dividend Years	23
Dividend Yield	6.27%
Ex Div Date	2026-03-17
Last Dividend	EUR 0.24
Payout Frequency	Semi-Annual
Payout Ratio	52.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	18.63%
1Y total return	14.49%
200-day SMA	4.52
3Y total return	-18.77%
50-day SMA	4.54
50-day SMA vs 200-day SMA	50over200
5Y total return	51.7%
All Time High	7.75
All Time High Change	-39.87%
All Time High Date	2024-10-22
All Time Low	0.2
All Time Low Change	2,230%
All Time Low Date	2004-05-31
ATR	0.06
Ch YTD	10.95
High	4.7
High52	5.65
High52 Date	2026-02-27
High52ch	-17.52%
Low	4.66
Low52	3.44
Low52 Date	2025-06-27
Low52ch	35.47%
Ma50ch	2.64%
Price vs 200-day SMA	3.05%
RSI	58.41
RSI Monthly	47.9
RSI Weekly	52.1
Sharpe ratio	0.48x
Sortino ratio	0.9
Total Return	6.26%
Tr YTD	17.02
Tr15y	717.55%
Tr1m	8.88%
Tr1w	0.43%
Tr3m	9.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 244M
Operating Income Growth	3.46
Operating Income Growth Q	4.02
Operating Income Growth3 Y	9.23
Operating Income Growth5 Y	74.32
Operating margin	36.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	713,107,600%
Net Borrowing	-955,508.3
Shares Insiders	2.08%
Shares Institutions	45.17%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 133.1M
Average Volume	0x
Bv Per Share	1.09
CAPEX	EUR -71.4M
Ch10y	-6.8
Ch15y	484.7
Ch1m	8.88
Ch1w	0.43
Ch1y	7.37
Ch20y	497.4
Ch3m	3.56
Ch3y	-27.19
Ch5y	30.9
Ch6m	1.75
Change	-0.85%
Change From Open	-0.85
Close	4.7
Days Gap	0
Depreciation Amortization	25,269,352.4
Dollar Volume	1,267.5
Earnings Date	2026-04-23
EBIT	EUR 244M
EBITDA	EUR 269.5M
EPS	EUR 0.23
F Score	6
FCF	EUR 133.1M
FCF EV Yield	3.95x
Financing CF	-108,899,698
Fiscal Year End	December
Founded	1,975
Goodwill	1,467,408
Graham Number	2.47978
Graham Upside	-46.79
Income Tax	EUR 47M
Investing CF	-77,536,552
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 6.26
Lynch Upside	34.36
Ma150	4.49
Ma150ch	3.81%
Ma20	4.53
Ma20ch	2.98%
Net CF	17,982,531
Next Earnings Date	2026-08-14
Open	4.7
P FCF Ratio	28.11
P OCF Ratio	18.3
Payment Date	2026-05-12
Position In Range	0
Ppne	382,357,410.8
Price Date	2026-05-08
Price EBITDA	EUR 13.89
Ptbv Ratio	4.41
Relative Volume	20x
Revenue	677,400,291x
Tax By Revenue	6.95x
Tax Rate	18.85%
Tr20y	1,973.06%
Tr6m	7.31%
Volume	272
Z Score	16.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/BZ7A dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.3%

$0.29 annual per share

Payout ratio

+52.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+28.0%

4 consecutive years of growth

Total shareholder yield

+6.3%

Next ex-dividend date: 2026-03-17

Performance

FRA/BZ7A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/BZ7A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.2%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

FRA/BZ7A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.4

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/BZ7A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BZ7A stock rating?

fra/BZ7A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BZ7A analysis?

The full report lives at /stocks/fra/BZ7A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BZ7A?

The latest report frames fra/BZ7A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BZ7A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.